The weight-loss drug market is evolving at a rapid speed, with leading pharma companies including Novo Nordisk and Eli Lilly ...

The U.S. stock market was down for the week despite a positive Friday, as tariff developments from the Trump administration ...

Novo Nordisk is also pairing the long-acting insulin with its once-weekly GLP-1 agonist semaglutide in the COMBINE trials programme, which is due to complete in 2024, is also working on a glucose ...

Clara Peek, an expert on circadian rhythms, says small changes — like shifting sleep and meal times — can make a big difference when the clocks move forward Sunday.

Yahoo Finance will chronicle the latest news and updates on Trump's tariffs — from the threats to the eventual policy.